1-10 of 10
Marta Dragosky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Therapeutic Approach to Advanced Follicular Lymphoma at Diagnosis: An Argentinian Survey

German R. Stemmelin, MD, Marta Dragosky, MD, Adriana Vitriu, MD, maria Julia Caffaro, MD, Miguel A Pavlovsky, MD, Marisa Marquez, MD, Astrid Pavlovsky, Dardo Alberto Riveros, MD, Lucia Zoppegno, MD, Rivas maria Marta, MD, Garatte Gonzalo, MD, Georgina Bendek, Marta Zerga, MD, Andrea Rodriguez, MD, Susana Cerana, MD, Diego Fernandez, MD, Maria amoroso Copello, MD, Graciela Alfonso, MD, Virginia Canonico, MD, Mercedes Gomez, Emilio Lanari, MD, Claudio d'Antonio, MD, Florencia Baglioni, MD, Sebastian Prieto, MD, Silvina Palmer, MD, Daniel Gotta, MD, Isabel Cristina Annetta, MD, Norma E. Tartas, MD
Journal: Blood
Blood (2014) 124 (21): 4408.
https://doi.org/10.1182/blood.V124.21.4408.4408
Published: 2014
Journal Articles

New Prognostic Factors in the Assessment of Bone Complications in Gaucher Disease. Report from the Argentinian Group for Diagnostic and Treatment for Gaucher Disease

Guillermo I. Drelichman, MD, Nicolas Fernandez Escobar, MD, Nora F Basack, MD, Maria S Larroude, MD, Gabriel Aguilar, MD, Hugo Robledo, MD, Leonardo J Feldman, MD, Graciela Elena, MD, Nora Watman, MD, Moira Bolesina, MD, Juan Jose Chain, MD, Paola Reichel, MD, Alba A Ruiz, MD, Maria F Cuello, MD, Alcira B Fynn, MD, Marcela A Aznar, MD, Marta Dragosky, MD, Norberto B Guelbert, MD, Adriana Arizo, MD, Graciela A Pujal, MD, Katja G Muller, MD
Journal: Blood
Blood (2014) 124 (21): 4116.
https://doi.org/10.1182/blood.V124.21.4116.4116
Published: 2014
Journal Articles

Eliglustat, an Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 4 Years of Treatment

M. Judith Peterschmitt, MD, Elena Lukina, PhD, MD, Nora Watman, MD, Marta Dragosky, M.D., Gregory M Pastores, Elsa Avila Arreguin, M.D., Hanna Rosenbaum, MD, Ari Zimran, MD, Elena Sysoeva, Rasha Aguzzi, Leorah H Ross, Ana Cristina Puga, M.D.
Journal: Blood
Blood (2012) 120 (21): 1038.
https://doi.org/10.1182/blood.V120.21.1038.1038
Published: 2012
Journal Articles

Improvements in Skeletal Manifestations in Gaucher Disease Type 1 Patients After 3 Years of Treatment with Oral Eliglustat During a Phase 2 Trial,

M. Judith Peterschmitt, MD, Ravi S Kamath, MD, Elena Lukina, PhD, MD, Nora Watman, MD, Marta Dragosky, M.D., Marcelo Iastrebner, M.D., Gregory M Pastores, Elsa Avila Arreguin, M.D., Mici Phillips, M.D., Hanna Rosenbaum, MD, Elena Sysoeva, Rasha Aguzzi, Leorah H Ross, Ana Cristina Puga, M.D., Daniel I Rosenthal, M.D.
Journal: Blood
Blood (2011) 118 (21): 3216.
https://doi.org/10.1182/blood.V118.21.3216.3216
Published: 2011
Journal Articles

Eliglustat, An Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 3 Years

M. Judith Peterschmitt, MD, Elena Lukina, PhD, MD, Nora Watman, MD, Marta Dragosky, M.D., Marcelo Iastrebner, M.D., Gregory Pastores, M.D., Elsa Avila Arreguin, M.D., Mici Phillips, M.D., Hanna Rosenbaum, MD, Elena Sysoeva, Rasha Aguzzi, Leorah H Ross, Ana Cristina Puga, M.D.
Journal: Blood
Blood (2011) 118 (21): 1104.
https://doi.org/10.1182/blood.V118.21.1104.1104
Published: 2011
Journal Articles

Eliglustat Tartrate, a Novel Investigational Oral Substrate Reduction Therapy for Gaucher Disease Type 1: Updated Phase 2 Results.

Elena Lukina, Judith Peterschmitt, Nora Watman, Marta Dragosky, Marcelo Iastrebner, Gregory Pastores, Elsa Avila Arreguin, Hanna Rosenbaum, Mici Phillips, Mathilde Kaper, Arshadul Haque, Ana Cristina Puga
Journal: Blood
Blood (2010) 116 (21): 3791.
https://doi.org/10.1182/blood.V116.21.3791.3791
Published: 2010
Journal Articles

Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study

Brief Report
Elena Lukina, Nora Watman, Elsa Avila Arreguin, Marta Dragosky, Marcelo Iastrebner, Hanna Rosenbaum, Mici Phillips, Gregory M. Pastores, Ravi S. Kamath, Daniel I. Rosenthal, Mathilde Kaper, Tejdip Singh, Ana Cristina Puga, M. Judith Peterschmitt
Journal: Blood
Blood (2010) 116 (20): 4095–4098.
https://doi.org/10.1182/blood-2010-06-293902
Published: 2010
Journal Articles

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1

Clinical Trials & Observations
Elena Lukina, Nora Watman, Elsa Avila Arreguin, Maryam Banikazemi, Marta Dragosky, Marcelo Iastrebner, Hanna Rosenbaum, Mici Phillips, Gregory M. Pastores, Daniel I. Rosenthal, Mathilde Kaper, Tejdip Singh, Ana Cristina Puga, Peter L. Bonate, M. Judith Peterschmitt
Journal: Blood
Blood (2010) 116 (6): 893–899.
https://doi.org/10.1182/blood-2010-03-273151
Published: 2010
Journal Articles

Genz-112638 for Gaucher Disease Type 1: Phase 2 Clinical Trial Results After 18 Months of Treatment.

Judith Peterschmitt, MD, Elena Lukina, PhD, MD, Nora Patricia Watman, MD, Elsa Avila Arreguin, MD, Maryam Banikazemi, MD, Gregory Pastores, MD, Marcelo Iastrebner, MD, Marta Dragosky, MD, Hanna Rosenbaum, MD, Mici Phillips, MD, Mathilde Kaper, Tejdip Singh, MD, Ana Cristina Puga, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1349.
https://doi.org/10.1182/blood.V114.22.1349.1349
Published: 2009
Journal Articles

Solitary Plasmacytoma. Presentation of 22 Cases of Two Centres from Buenos Aires, Argentina

Marta Dragosky, MD, Susana Alcaraz, MD, Isabel Anetta, MD, Ariel Corzo, MD, Laura Devotto, MD, Ernesto Gil Deza, MD, Patricia Luchetta, MD, Marisa Marquez, MD
Journal: Blood
Blood (2008) 112 (11): 5206.
https://doi.org/10.1182/blood.V112.11.5206.5206
Published: 2008